LOZAPINE 25 MG

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

şimdi satın al

Aktif bileşen:

CLOZAPINE

Mevcut itibaren:

TARO INTERNATIONAL LTD, ISRAEL

ATC kodu:

N05AH02

Farmasötik formu:

TABLETS

Kompozisyon:

CLOZAPINE 25 MG

Uygulama yolu:

PER OS

Reçete türü:

Required

Tarafından üretildi:

GENTHON B.V.

Terapötik grubu:

CLOZAPINE

Terapötik alanı:

CLOZAPINE

Terapötik endikasyonlar:

Treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics.Reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state.Suicidal behavior refers to actions by a patient that put him/herself at risk for death

Yetkilendirme tarihi:

2020-04-30

Bilgilendirme broşürü

                                Lozapine – Notification 03.21 - ENG
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS
(PREPARATIONS) - 1986
This medicine is dispensed with a doctor's prescription only
LOZAPINE 25 MG
TABLETS
LOZAPINE 100 MG
TABLETS
Active ingredient and quantity:
Active ingredient and quantity:
Each tablet contains:
Each tablet contains:
clozapine 25 mg
clozapine 100 mg
Inactive ingredients and allergens: See section 2 under ‘Important
information about some of this medicine’s ingredients’ and section
6
‘Additional information’.
PREPARATION DISPENSING INSTRUCTIONS:
DURING THE FIRST 18 WEEKS:
PERFORM A BLOOD TEST ONCE A WEEK DURING THE FIRST 18 WEEKS.
THE COMMUNITY PHARMACY WILL DISPENSE THE MEDICINE FOR ONE WEEK
OF TREATMENT ONLY, ACCORDING TO A DOCTOR'S PRESCRIPTION, PROVIDED
THAT IT CARRIES THE STAMP:
“WHITE BLOOD CELL TEST WAS PERFORMED, AND THE RESULTS ARE NORMAL”.
STARTING FROM WEEK 19 OF TREATMENT:
A BLOOD TEST MUST BE PERFORMED AT LEAST ONCE A MONTH.
THE COMMUNITY PHARMACY WILL DISPENSE THE MEDICINE FOR ONE MONTH
OF TREATMENT ONLY, ACCORDING TO A DOCTOR'S PRESCRIPTION, PROVIDED
THAT IT CARRIES THE STAMP:
“WHITE BLOOD CELL TEST WAS PERFORMED, AND THE RESULTS ARE NORMAL”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE. This leaflet contains concise information about this
medicine.
If you have any further questions, consult your doctor or pharmacist.
This medicine has been prescribed to treat your illness. Do not pass
it
on to others. It may harm them, even if it seems to you that their
illness
is similar to yours.
Before starting treatment with Lozapine, blood tests must be performed
to
make sure that you can take the medicine.
1.
WHAT IS THIS MEDICINE INTENDED FOR?
Lozapine is used for treatment in resistant schizophrenic patients who
are
non-responsive to, or intolerant of other antipsychotic medicines.
The medicine is also intended for reducing the risk of recurrent
suicidal
behaviour in patients with schizophrenia or schizoaffective disorder
who
are long-term ris
                                
                                Belgenin tamamını okuyun
                                
                            

Diğer dillerdeki belgeler

Bilgilendirme broşürü Bilgilendirme broşürü Arapça 25-04-2021
Bilgilendirme broşürü Bilgilendirme broşürü İbranice 25-04-2021

Bu ürünle ilgili arama uyarıları

Belge geçmişini görüntüleyin